Status:
COMPLETED
Pancreatectomy for NET: External Evaluation of WHO 2017 Grading System
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Department of digestive surgery, Carémeau Hospital, 30900, Nîmes, France
Department of oncology, Carémeau Hospital, 30900, Nîmes, France
Conditions:
Pancreatic Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Aim: The aim of this study was to investigate the clinicopathological factors and to evaluate the prognostic accuracy of the new World Health Organization (WHO) 2017 grading system in pancreatic neuro...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- patients with histologically proven neuroendocrine tumor located in pancreas who underwent pancreatic resection (by open, laparoscopic or robotic approach) even in case of distant metastasis at time of surgery, with no previous or concurrent malignancy.
- Exclusion criteria:
- \- Patients with tumors diagnosed as adenocarcinoma with scattered neuroendocrine cells or with focal neuroendocrine component were excluded of this study.
Exclusion
Key Trial Info
Start Date :
January 1 1997
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT03791346
Start Date
January 1 1997
End Date
February 1 2019
Last Update
April 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295